Inhaled Low‐Dose Iloprost for Pulmonary Hypertension: A Prospective, Multicenter, Open‐Label Study

BACKGROUND: Inhaled iloprost (average >30 µg/d) has been considered an effective treatment for severe pulmonary hypertension (PH). Further evidence also showed that low‐dose iloprost given intravenously was equally effective as high‐dose iloprost in the therapy of systemic sclerosis. HYPOTHESIS:...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Clin Cardiol
Prif Awduron: Sun, Yun‐Juan, Xiong, Chang‐Ming, Shan, Guang‐Liang, Gu, Qing, Zeng, Wei‐Jie, Lu, Xian‐Ling, Zhu, Feng, Liu, Zhi‐Hong, Ni, Xin‐Hai, He, Jian‐Guo
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Wiley Periodicals, Inc. 2012
Pynciau:
Clinical Investigations
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6652663/
https://ncbi.nlm.nih.gov/pubmed/22488211
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/clc.21987
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg